|
Volumn 42, Issue 4, 2001, Pages 586-590
|
Impact of 18F-FDG PET on managing patients with colorectal cancer: The referring physician's perspective
a a a a a a a a a |
Author keywords
Colorectal cancer; PET; Survey
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER THERAPY;
COLORECTAL CANCER;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL DECISION MAKING;
MEDICAL PRACTICE;
PHYSICIAN;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
QUESTIONNAIRE;
TREATMENT PLANNING;
COLORECTAL TUMOR;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
MEDICINE;
MIDDLE AGED;
PATHOLOGY;
PATIENT REFERRAL;
SCINTISCANNING;
ADULT;
AGED;
AGED, 80 AND OVER;
COLORECTAL NEOPLASMS;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
QUESTIONNAIRES;
RADIOPHARMACEUTICALS;
REFERRAL AND CONSULTATION;
SPECIALTIES, MEDICAL;
TOMOGRAPHY, EMISSION-COMPUTED;
|
EID: 0034744518
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (123)
|
References (25)
|